Patents by Inventor Gilda Tachedjian

Gilda Tachedjian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic method
    Patent number: 9801839
    Abstract: The present invention relates generally to a method of down-regulating an inflammatory response in a mammal and to agents useful for same. More particularly, the present invention relates to a method of down-regulating an inflammatory response in the reproductive tract or external genital tissue of a female mammal by contacting the mucosal tissue of the reproductive tract and/or genitalia with lactic acid and to agents useful for same. The method of the present invention is useful, inter alia, in the treatment and/or prophylaxis of conditions characterised by an aberrant, unwanted or otherwise inappropriate inflammatory response including, for example, atrophic vaginitis, irritant vaginitis or infectious vaginitis.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: October 31, 2017
    Assignee: Macfarlane Burnet Institute for Medical Research and Public Health Pty Ltd
    Inventors: Gilda Tachedjian, Anna Hearps
  • THERAPEUTIC METHOD
    Publication number: 20150306053
    Abstract: The present invention relates generally to a method of down-regulating an inflammatory response in a mammal and to agents useful for same. More particularly, the present invention relates to a method of down-regulating an inflammatory response in the reproductive tract or external genital tissue of a female mammal by contacting the mucosal tissue of the reproductive tract and/or genitalia with lactic acid and to agents useful for same. The method of the present invention is useful, inter alia, in the treatment and/or prophylaxis of conditions characterised by an aberrant, unwanted or otherwise inappropriate inflammatory response including, for example, atrophic vaginitis, irritant vaginitis or infectious vaginitis.
    Type: Application
    Filed: February 27, 2015
    Publication date: October 29, 2015
    Applicant: Macfarlane Burnet Institute for Medical Research and Public Health Pty Ltd
    Inventors: Gilda Tachedjian, Anna Hearps
  • Two hybrid assay that detects HIV-1 reverse transcriptase dimerization
    Patent number: 6812025
    Abstract: This invention provides methods of determining whether a compound inhibits HIV-1 reverse transcriptase. This invention provides methods of determining whether a compound inhibits formation of a complex between a p66 and p51 subunit polypeptides of HIV-1 reverse transcriptase. This invention provides a method of determining whether a compound enhances formation of a complex between a p66 and p51 subunit polypeptides of HIV-1 reverse transcriptase. This invention provides methods of determining whether a compound inhibits formation of a complex between two p66 subunit polypeptides of HIV-1 reverse transcriptase. This invention provides methods of determining whether a compound enhances formation of a complex between two p66 subunit polypeptides of HIV-1 reverse transcriptase.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: November 2, 2004
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Stephen P. Goff, Gilda Tachedjian
  • Two-hybrid assay that detects HIV-1 reverse transcriptase dimerization
    Publication number: 20030007983
    Abstract: This invention provides methods of determining whether a compound inhibits HIV-1 reverse transcriptase. This invention provides methods of determining whether a compound inhibits formation of a complex between a p66 and p51 subunit polypeptides of HIV-1 reverse transcriptase. This invention provides a method of determining whether a compound enhances formation of a complex between a p66 and p51 subunit polypeptides of HIV-1 reverse transcriptase. This invention provides methods of determining whether a compound inhibits formation of a complex between two p66 subunit polypeptides of HIV-1 reverse transcriptase. This invention provides methods of determining whether a compound enhances formation of a complex between two p66 subunit polypeptides of HIV-1 reverse transcriptase.
    Type: Application
    Filed: December 6, 2001
    Publication date: January 9, 2003
    Inventors: Stephen P. Goff, Gilda Tachedjian, Bryan Mark O'Hara
  • Two hybrid assay that detects hiv-1 reverse transcriptase dimerization
    Publication number: 20020197598
    Abstract: This invention provides methods of determining whether a compound inhibits HIV-1 reverse transcriptase. This invention provides methods of determining whether a compound inhibits formation of a complex between a p66 and p51 subunit polypeptides of HIV-1 reverse transcriptase. This invention provides a method of determining whether a compound enhances formation of a complex between a p66 and p51 subunit polypeptides of HIV-1 reverse transcriptase. This invention provides methods of determining whether a compound inhibits formation of a complex between two p66 subunit polypeptides of HIV-1 reverse transcriptase. This invention provides methods of determining whether a compound enhances formation of a complex between two p66 subunit polypeptides of HIV-1 reverse transcriptase.
    Type: Application
    Filed: June 12, 2002
    Publication date: December 26, 2002
    Inventors: Stephen P. Goff, Gilda Tachedjian